20-H3

N/A

Report date: 2025/06/26 09:45:19
First In Class

Base Information

Drug Name20-H3
Drug Alias Name20H320-H3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Transient receptor potential cation channel subfamily V member 6
TargetsTransient receptor potential cation channel subfamily V member 6
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMabqi SAS
China Registration ClassN/A

Develop Information

Active CompaniesMabqi SAS
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A